Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention

Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trial...

Descripción completa

Detalles Bibliográficos
Autor principal: Srivastava, Padma
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Review: Management Updates
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859581/
https://www.ncbi.nlm.nih.gov/pubmed/20436740
http://dx.doi.org/10.4103/0972-2327.61270
_version_ 1782180522005364736
author Srivastava, Padma
author_facet Srivastava, Padma
author_sort Srivastava, Padma
collection PubMed
description Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trials, on different antiplatelet regimes and the risk assessment that may be unique to each patient.
format Text
id pubmed-2859581
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28595812010-04-30 Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention Srivastava, Padma Ann Indian Acad Neurol Review: Management Updates Role of antiplatelet therapy in secondary stroke prevention is of major significance. Antiplatelet agents predominantly in use are aspirin, clopidogrel, and combination regimes. The review focuses on the optimization of antiplatelet regimen based on evidence obtained from randomized-controlled trials, on different antiplatelet regimes and the risk assessment that may be unique to each patient. Medknow Publications 2010 /pmc/articles/PMC2859581/ /pubmed/20436740 http://dx.doi.org/10.4103/0972-2327.61270 Text en © Annals of Indian Academy Neurology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review: Management Updates
Srivastava, Padma
Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
title Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
title_full Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
title_fullStr Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
title_full_unstemmed Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
title_short Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
title_sort optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
topic Review: Management Updates
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859581/
https://www.ncbi.nlm.nih.gov/pubmed/20436740
http://dx.doi.org/10.4103/0972-2327.61270
work_keys_str_mv AT srivastavapadma optimizationofantiplateletantithrombotictherapyforsecondarystrokeprevention

Ejemplares similares